NAFCILLIN SODIUM
Generic: NAFCILLIN SODIUM
Armas Pharmaceuticals Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
NAFCILLIN SODIUMActive Substance
2014-04-07Original Approval
NAFCILLIN SODIUM is FDA application ANDA200002, sponsored by ONESOURCE SPECIALTY. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
RENAL FAILURE ACUTE
64 reports
2
DRUG INEFFECTIVE
56 reports
3
RASH
56 reports
4
ACUTE KIDNEY INJURY
49 reports
5
PYREXIA
44 reports
6
TUBULOINTERSTITIAL NEPHRITIS
43 reports
7
HYPOKALAEMIA
42 reports
8
RENAL FAILURE
39 reports
9
BLOOD CREATININE INCREASED
36 reports
10
DRUG INTERACTION
35 reports